CAMBRIDGE, Mass.—In a classic case of a desktop solution leveraging and improving an enterprise-wide data management system, CambridgeSoft Corp. and StatSoft Inc. announced in mid-December a collaboration that will integrate CambridgeSoft's Chem & Bio Office Suite of products with Statistica, StatSoft's data analytics software. Like many such collaborations, this one was fueled by repeated requests from common customers that were seeking a more functional and seamless integration of the two companies' core offerings.
According to Robert Eames, director of life sciences practice at Tulsa, Okla.-based StatSoft, conversations of working collaboratively with CambridgeSoft started roughly three years ago, then really heated up within the past year.
"There are a couple of major customers that we share with CambridgeSoft that had some open integration projects," Eames says. "While one was going through an upgrade, one of our overseas offices mentioned that it would help us in the market if we had a closer working relationship with CambridgeSoft because of the complementary nature of our products."
"With our assay management system, we collect all the data and push it out to Statistica to do sophisticated analysis and plotting," explains David Levy, executive director, enterprise applications, for CambridgeSoft. "Nine times out of 10, the data collected in this work is biology data. But that data is connected very often to other chemistry data, which we've also captured, and experimental data, which might be captured in E-Notebook. The CambridgeSoft enterprise software provides the tools to connect all of those pieces together."
Being able to easily relate specific experimental data, with diverse data sets scattered among the enterprise and captured from a variety sources, Levy notes, is one of the core missions of CambridgeSoft, as it seeks to unlock the potential locked away in large pharma companies' data silos and serves as a way to "magnify" the added value of the StatSoft-CambridgeSoft collaboration.
Moving forward with the integration now also made sense, according to Eames, since the companies were on similar upgrade cycles with the intent to release the upgrades in the first quarter of this year.
Initially, the distribution model will see CambridgeSoft offering Statistica most likely as an option to its existing enterprise platform, Levy says, though the exact method of distribution was still to be determined at press time.
While CambridgeSoft has done similar integrations in the past with other companies, including Waters and Agilent, Levy notes those activities were "one-off" activities. According to both Eames and Levy, the Statistica integration likely represents only the beginning of a longer-term relationship between the two companies, both in terms of integrating additional products, as well as the potential to provide additional sales leads. DDN
According to Robert Eames, director of life sciences practice at Tulsa, Okla.-based StatSoft, conversations of working collaboratively with CambridgeSoft started roughly three years ago, then really heated up within the past year.
"There are a couple of major customers that we share with CambridgeSoft that had some open integration projects," Eames says. "While one was going through an upgrade, one of our overseas offices mentioned that it would help us in the market if we had a closer working relationship with CambridgeSoft because of the complementary nature of our products."
"With our assay management system, we collect all the data and push it out to Statistica to do sophisticated analysis and plotting," explains David Levy, executive director, enterprise applications, for CambridgeSoft. "Nine times out of 10, the data collected in this work is biology data. But that data is connected very often to other chemistry data, which we've also captured, and experimental data, which might be captured in E-Notebook. The CambridgeSoft enterprise software provides the tools to connect all of those pieces together."
Being able to easily relate specific experimental data, with diverse data sets scattered among the enterprise and captured from a variety sources, Levy notes, is one of the core missions of CambridgeSoft, as it seeks to unlock the potential locked away in large pharma companies' data silos and serves as a way to "magnify" the added value of the StatSoft-CambridgeSoft collaboration.
Moving forward with the integration now also made sense, according to Eames, since the companies were on similar upgrade cycles with the intent to release the upgrades in the first quarter of this year.
Initially, the distribution model will see CambridgeSoft offering Statistica most likely as an option to its existing enterprise platform, Levy says, though the exact method of distribution was still to be determined at press time.
While CambridgeSoft has done similar integrations in the past with other companies, including Waters and Agilent, Levy notes those activities were "one-off" activities. According to both Eames and Levy, the Statistica integration likely represents only the beginning of a longer-term relationship between the two companies, both in terms of integrating additional products, as well as the potential to provide additional sales leads. DDN
